IndraLab

Statements

Ruxolitinib inhibits IFNB1. 1 / 1

| 1

reach

"Inhibition of IFN-beta signaling by ruxolitinib reduced rli32 dependent intracellular bacterial growth, indicating a link between induction of the interferon system and bacterial physiology."

31594810

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Ruxolitinib inhibits IFNB1. 1 / 1

INDRA sources:

Databases

Reading